Overview
Yujiro Takai practices in Omorinaka, Japan. Takai is rated as an Advanced expert by MediFind in the treatment of Interstitial Lung Disease. Their top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, and Pneumonia.
Their clinical research consists of co-authoring 33 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 8 articles in the study of Interstitial Lung Disease.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Interstitial Pneumonia
- EGFR Positive Lung Cancer
- Hypersensitivity Pneumonitis
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Lung AdenocarcinomaTakai isAdvanced. Learn about Lung Adenocarcinoma.
- Experienced
- Cerebral HypoxiaTakai isExperienced. Learn about Cerebral Hypoxia.
- EmphysemaTakai isExperienced. Learn about Emphysema.
- EmpyemaTakai isExperienced. Learn about Empyema.
- Lymphofollicular HyperplasiaTakai isExperienced. Learn about Lymphofollicular Hyperplasia.
- Mediastinal TumorTakai isExperienced. Learn about Mediastinal Tumor.
- Non-Small Cell Lung Cancer (NSCLC)